Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen Springer

Showing results (1-10 of 152) with videos related to

Pageof 16
Sort By:
Journal of Cachexia, Sarcopenia and Muscle|May 29, 2012
Evidence for an effect of ACE inhibitors on cancer cachexiaNancy Schanze, Jochen Springer
Journal of Cachexia, Sarcopenia and Muscle|November 15, 2012
Bile acids for cachexia therapy : Reply to the letter by Shailendra Kapoor: Ursodeoxycholic acid and its emerging role in attenuation of tumor growth in gastrointestinal malignanciesAnika Tschirner, Jochen Springer
Journal of Cachexia, Sarcopenia and Muscle|October 4, 2011
Breakthrough in cachexia treatment through a novel selective androgen receptor modulator?!Thomas Thum, Jochen Springer
Journal of Cachexia, Sarcopenia and Muscle|January 31, 2019
MicroRNAs in muscle wastingTsuyoshi Suzuki, Jochen Springer
International Journal of Cardiology|September 17, 2017
Reply to letter to the editor "suramin against myostatin signaling may be considered to intervene in female patients with advanced heart failure"Junichi Ishida, Jochen Springer
Journal of Cachexia, Sarcopenia and Muscle|December 1, 2020
Biomarkers for cancer cachexia: where do we stand?Sandra Palus, Jochen Springer
Journal of the American Medical Directors Association|November 24, 2015
Treatment of Muscle Wasting: An Overview of Promising Treatment TargetsStephan von Haehling, Jochen Springer
Expert Opinion on Drug Discovery|July 25, 2012
The underestimated impact of cachexiaJochen Springer, Stefan D Anker
Drugs & Aging|November 11, 2016
ACE Inhibitors and Sarcopenia: Covering All the BASEs?Jochen Springer, Stephan von Haehling
Wiener Klinische Wochenschrift|November 26, 2016
Publication trends in cachexia and sarcopenia in elderly heart failure patientsJochen Springer, Stefan D Anker
Pageof 16

Showing results (1-10 of 152) with videos related to

Sort By:
Pageof 16
Journal of Cachexia, Sarcopenia and Muscle|May 29, 2012
Evidence for an effect of ACE inhibitors on cancer cachexiaNancy Schanze, Jochen Springer
Journal of Cachexia, Sarcopenia and Muscle|November 15, 2012
Bile acids for cachexia therapy : Reply to the letter by Shailendra Kapoor: Ursodeoxycholic acid and its emerging role in attenuation of tumor growth in gastrointestinal malignanciesAnika Tschirner, Jochen Springer
Journal of Cachexia, Sarcopenia and Muscle|October 4, 2011
Breakthrough in cachexia treatment through a novel selective androgen receptor modulator?!Thomas Thum, Jochen Springer
Journal of Cachexia, Sarcopenia and Muscle|January 31, 2019
MicroRNAs in muscle wastingTsuyoshi Suzuki, Jochen Springer
International Journal of Cardiology|September 17, 2017
Reply to letter to the editor "suramin against myostatin signaling may be considered to intervene in female patients with advanced heart failure"Junichi Ishida, Jochen Springer
Journal of Cachexia, Sarcopenia and Muscle|December 1, 2020
Biomarkers for cancer cachexia: where do we stand?Sandra Palus, Jochen Springer
Journal of the American Medical Directors Association|November 24, 2015
Treatment of Muscle Wasting: An Overview of Promising Treatment TargetsStephan von Haehling, Jochen Springer
Expert Opinion on Drug Discovery|July 25, 2012
The underestimated impact of cachexiaJochen Springer, Stefan D Anker
Drugs & Aging|November 11, 2016
ACE Inhibitors and Sarcopenia: Covering All the BASEs?Jochen Springer, Stephan von Haehling
Wiener Klinische Wochenschrift|November 26, 2016
Publication trends in cachexia and sarcopenia in elderly heart failure patientsJochen Springer, Stefan D Anker
Pageof 16